Sort by
Refine Your Search
-
Country
-
Field
-
therapy and has supported over 100 clinical trials. In April 2020 the CBF produced ChAdOx1 nCoV-19, the UK’s first COVID-19 vaccine to enter clinical trials. Later acquired by AstraZeneca, billions of doses
-
companies such as AstraZeneca. The collaboration with industry, universities, and research infrastructures ensures access to cutting-edge expertise and advanced research resources. The project includes two
-
well as with advice from leading pharmaceutical companies such as AstraZeneca. The collaboration with industry, universities and research infrastructures ensures access to cutting-edge expertise and advanced
-
‑cell platforms. Working closely with clinical, regulatory, manufacturing and academic collaborators, you will interpret complex datasets in real time to inform critical programme decisions. You will
-
cell-cell interactions to disrupt cancer-promoting equilibria. We aim to develop in silico and in vitro models and tools to build and validate digital twins of such interactions, with the objective
-
classrooms, media and gaming labs, human–computer interaction research labs, usability and mobile development labs, ample research facilities, and studios for sound design and interactive media production
-
. Furthermore, the functional consequences of any such regulation will be investigated. Techniques: The project will provide excellent training in a range of techniques associated with molecular biology, cell